Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
INTRAOPERATIVE AUTOLOGOUS BLOOD-TRANSFUSION IN INTRACRANIAL SURGERY
Autore:
CATALDI S; BRUDER N; DUFOUR H; LEFEVRE P; GRISOLI F; FRANCOIS G;
Indirizzi:
CHU TIMONE ADULTES,DEPT ANESTHESIE REANIMAT F-13385 MARSEILLE 5 FRANCE CHU TIMONE ADULTES,SERV NEUROCHIRURG F-13385 MARSEILLE 5 FRANCE CHU TIMONE ADULTES,SERV HEMOBIOL F-13385 MARSEILLE 5 FRANCE
Titolo Testata:
Neurosurgery
fascicolo: 4, volume: 40, anno: 1997,
pagine: 765 - 771
SICI:
0148-396X(1997)40:4<765:IABIIS>2.0.ZU;2-G
Fonte:
ISI
Lingua:
ENG
Soggetto:
AUTO-TRANSFUSION; AUTOTRANSFUSION; COAGULOPATHY; SALVAGE; CELLS;
Keywords:
AUTOLOGOUS BLOOD TRANSFUSION; BLOOD SAVINGS; INTRACRANIAL SURGERY;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Science Citation Index Expanded
Citazioni:
31
Recensione:
Indirizzi per estratti:
Citazione:
S. Cataldi et al., "INTRAOPERATIVE AUTOLOGOUS BLOOD-TRANSFUSION IN INTRACRANIAL SURGERY", Neurosurgery, 40(4), 1997, pp. 765-771

Abstract

OBJECTIVE: The purpose of this study was to evaluate the benefits of intraoperative autotransfusion of autologous blood on the conservationof allogenic blood, including cost-effectiveness and the consequencesfor hemoglobin level and coagulation tests. METHODS: The Haemonetics Cell Saver 4 autotransfusion system (Haemonetics Corporation, MA) was used when the estimated blood loss was equal to or more than 500 ml. Atotal of 472 patients undergoing intracranial surgery were included in the study. RESULTS: Ninety patients (19%) received transfusions either with autologous blood or allogenic blood. Fifty-five patients (61%)received only autologous blood transfusions, 10 patients (11%) received both autologous and allogenic blood transfusions, and 25 patients (28%) received only allogenic blood transfusions. The amount of autologous blood transfused was 600 +/- 590 mi (range, 230-3000 ml). The amount of allogenic blood transfused was 3 +/- 3 units (range, 2-15 units). Autologous blood represented 68% of all blood products transfused. Mild abnormalities during coagulation tests occurred without clinical bleeding. CONCLUSION: Autologous blood transfusions were demonstrated to be safe in patients undergoing intracranial surgery and to be more cost-effective than allogenic blood transfusions. Intraoperative autologous blood transfusions may be used alone in more than half of the patients requiring transfusions during intracranial surgery and decrease the amount of allogenic blood used. Improvements in the monitoring forthe need of performing this technique, as well as preoperative blood donations, would decrease the amount of allogenic blood transfused.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/11/20 alle ore 06:41:19